Advertisement

POZ September 2019

POZ September 2019

In every issue, you’ll find the hottest topics of interest to our readers along with cutting-edge health information.

Also Available On:

ISSUU

Features

Jeff Taylor

Older & Wiser

How HIV long-term survivors contribute to a better future for everyone

Elizabeth Taylor

25 Years of Celebrities

Our esteem for their HIV activism—from the red carpet to beyond—is a constant.

Paul Kawata

Yours in the Struggle

Honoring 30 Years at NMAC

Editor’s Letter

Oriol R. Gutierrez

Better Together

For this special issue on aging and HIV, we spoke to a coalition called the HIV+Aging Research Project—Palm Springs (HARP-PS).

POZ Q+A

U=U campaign

U=U 2.0

Prevention Access Campaign builds on its success with a new executive director of North America.

POZ Planet

POZ 2009 cover

POZ at 25 — September

A look at September issues from the POZ archives

Celeste Watkins-Hayes of Northwestern University

Stories of Resilience

Two HIV researchers discuss their recent books on gay men and HIV-positive women.

Everyday

condom red wrapper

Everyday — September 2019

Here are some important dates in AIDS history.

Voices

bare lit lightbuld in socket hanging

Just One

POZ contributing writer Shawn Decker shares his journey from being a kid with no real treatment options to now.

magnifying glass on paper with big red ME

No Thanks

Andrew Spieldenner, PhD, chair of the U.S. People Living with HIV Caucus, explores the concept of gratitude in the HIV field.

Care And Treatment

red calendar on yellow background

Rapid Treatment Works

Starting Symtuza quickly after HIV diagnosis is tied to high viral suppression.

sad woman by window

Women’s Detectable HIV Risk

Many women on HIV treatment are at risk of developing a detectable viral load.

needle inserted into vial

Long-Acting HIV Meds

Recently, ViiV Healthcare applied for approval of the first long-acting injectable HIV regimen.

doctor holding a hand

Hep C Treatment Works Really Well

Researchers conducted an analysis of hep C treatment outcomes in those also living with HIV in Western nations.

Research Notes

arm and hand holding up a card with zero

Prevention: Zero Transmissions

Final results from the PARTNER 2 study of gay and bi men confirm that undetectable equals untransmittable.

IV bottle

Treatment: Long-Acting Antibody

CCR5-blocking antibody leads to long-term HIV suppression

printed map showing France

Cure: Trial Transmission

A French man with HIV transmitted the virus to his partner while off meds during a cure trial.

silhouette of woman from behind

Concerns: Women’s Disparities

Black women have a HIV rate 15 times higher than white women.

Heroes

LaTrischa Miles

Healing Through Grace

LaTrischa Miles encourages women to engage in their health care.

Survey

heart stethoscope hand ipone

E-Health

Digital Edition

POZ September 2019 cover

POZ September 2019

Read the digital edition!

Advertisement

Hot topics